Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. LICENSE AND COLLABORATION AGREEMENT by and among Takeda Pharmaceutical Company Limited and Alnylam Pharmaceuticals, Inc. Dated...License and Collaboration Agreement • August 8th, 2008 • Alnylam Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This LICENSE AND COLLABORATION AGREEMENT (this “Agreement”) is entered into as of May 27, 2008 (the “Effective Date”), by and among Takeda Pharmaceutical Company Limited, a Japanese corporation, having a place of business at 1-1, Doschomachi 4-chome, Chuo-ku, Osaka 540-8645, Japan (“Takeda”), and Alnylam Pharmaceuticals, Inc., a Delaware corporation, having a place of business at 300 Third Street, 3rd Floor, Cambridge, Massachusetts 02142, USA (“Alnylam”).
